Key Opinion Leader Webinar Discussing Progression of Childhood-onset STGD1 and Relevance of the Tinlarebant 18-month Phase 2 Data | Belite Bio, Inc.

Key Opinion Leader Webinar Discussing Progression of Childhood-onset STGD1 and Relevance of the Tinlarebant 18-month Phase 2 Data

START-ONLY May 10, 2023 at 1:00 PM EDT

Join our mailing list.

Sign up to receive important updates and news from Belite Bio